{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:58:36Z","timestamp":1771952316557,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06837-0","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:11:48Z","timestamp":1771056708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive geriatric assessment (CGA) scale does not effectively identify elderly AML patients suitable for intensive induction chemotherapy \u2013 a multicenter study from Polish Adult Leukemia Group"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-4099","authenticated-orcid":false,"given":"Bo\u017cena Katarzyna","family":"Budziszewska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"\u0141omiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Barankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Patkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Bo\u0142kun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Irga-Staniukiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ki\u017cewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Piekarska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kocl\u0119ga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Pluta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Kuydowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylwia","family":"Ko\u015bcio\u0142ek-Zg\u00f3dka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edyta","family":"Cichocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Malenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Gromek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ma\u0142ecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Grosicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Giebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Wierzbowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Lech-Mara\u0144da","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"6837_CR1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM (2019) Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev 36:70\u201387. https:\/\/doi.org\/10.1016\/j.blre.2019.04.005","journal-title":"Blood Rev"},{"key":"6837_CR2","doi-asserted-by":"publisher","unstructured":"Yi M, Li A, Zhou L, Chu Q, Song Y, Wu K (2017) The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study. J Hematol Oncol. 2020;13:72. https:\/\/doi.org\/10.1186\/s13045-020-00908-z","DOI":"10.1186\/s13045-020-00908-z"},{"issue":"23","key":"6837_CR3","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND et al (2016) Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med 374(23):2209\u20132221. https:\/\/doi.org\/10.1056\/NEJMoa1516192","journal-title":"N Engl J Med"},{"issue":"2","key":"6837_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.01.013","volume":"67","author":"JF Piccirillo","year":"2008","unstructured":"Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67(2):124\u2013132. https:\/\/doi.org\/10.1016\/j.critrevonc.2008.01.013","journal-title":"Crit Rev Oncol Hematol"},{"key":"6837_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11912-020-00964-1","volume":"22","author":"M Abdallah","year":"2020","unstructured":"Abdallah M, Xie Z, Ready A, Manogna D, Mendler JH, Loh KP (2020) Management of acute myeloid leukemia (AML) in older patients. Curr Oncol Rep 22:103. https:\/\/doi.org\/10.1007\/s11912-020-00964-1","journal-title":"Curr Oncol Rep"},{"issue":"3","key":"6837_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/17474086.2023.2185603","volume":"16","author":"A Venditti","year":"2023","unstructured":"Venditti A, Cairoli R, Caira M, Finsinger P, Finocchiaro F, Neri B, De Benedittis D, Rossi G, Ferrara F (2023) Assessing eligibility for treatment in acute myeloid leukemia in 2023. Expert Rev Hematol 16(3):181\u2013190. https:\/\/doi.org\/10.1080\/17474086.2023.2185603","journal-title":"Expert Rev Hematol"},{"issue":"7","key":"6837_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"CD DiNardo","year":"2020","unstructured":"DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH et al (2020) Azacitidine and venetoclax in previously untreated acute myeloid leukemia. N Eng J Med 383(7):617\u2013629. https:\/\/doi.org\/10.1056\/NEJMoa2012971","journal-title":"N Eng J Med"},{"issue":"16","key":"6837_CR8","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa2117344","volume":"386","author":"P Montesinos","year":"2022","unstructured":"Montesinos P, Recher C, Vives S, Zarzycka E, Wang J, Bertani G et al (2022) Ivosidenib and Azacitidine in IDH1-Mutated acute myeloid leukemia. N Eng J Med 386(16):1519\u20131531. https:\/\/doi.org\/10.1056\/NEJMoa2117344","journal-title":"N Eng J Med"},{"issue":"13","key":"6837_CR9","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1056\/NEJMoa0901409","volume":"361","author":"B Lowenberg","year":"2009","unstructured":"Lowenberg B, Ossenkoppele GJ, van Schouten PW, Graux HC, Ferrant C A, et al (2009) High-dose Daunorubicin in older patients with acute myeloid leukemia. N Engl J Med 361(13):1235\u20131248. https:\/\/doi.org\/10.1056\/NEJMoa0901409","journal-title":"N Engl J Med"},{"issue":"9","key":"6837_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.clml.2021.05.016","volume":"21","author":"HM Kantarjian","year":"2021","unstructured":"Kantarjian HM, Short NJ, Fathi AT, Marcucci G, Ravandi F, Tallman M et al (2021) Acute myeloid leukemia: historical perspective and progress in research and therapy over 5 decades. Clin Lymphoma Myeloma Leuk 21(9):580\u2013597. https:\/\/doi.org\/10.1016\/j.clml.2021.05.016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"12","key":"6837_CR11","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Ravandi F, Kadia TM, DiNardo CD, Short NJ, Borthakur G et al (2021) De Novo acute myeloid leukemia: A population-based study of outcome in the united States based on the Surveillance, Epidemiology, and end results (SEER) database, 1980 to 2017. Cancer 127(12):2049\u20132061. https:\/\/doi.org\/10.1002\/cncr.33458","journal-title":"Cancer"},{"key":"6837_CR12","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22537","volume":"109","author":"A Etienne","year":"2007","unstructured":"Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D et al (2007) Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 109:1376\u20131383. https:\/\/doi.org\/10.1002\/cncr.22537","journal-title":"Cancer"},{"key":"6837_CR13","doi-asserted-by":"publisher","first-page":"101047","DOI":"10.1016\/j.arr.2020.101047","volume":"60","author":"A Pilotto","year":"2020","unstructured":"Pilotto A, Custodero C, Maggi S, Polidori MC, Veronese N, Ferrucci L (2020) A multidimensional approach to frailty in older people. Ageing Res Rev 60:101047. https:\/\/doi.org\/10.1016\/j.arr.2020.101047","journal-title":"Ageing Res Rev"},{"issue":"1","key":"6837_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jgo.2019.10.002","volume":"11","author":"HD Klepin","year":"2020","unstructured":"Klepin HD, Ritchie E, Major-Elechi B, Le-Rademacher J, Seisler D, Storrick L et al (2020) Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: report of CALGB 361006 (Alliance). J Geriatr Oncol 11(1):107\u2013113. https:\/\/doi.org\/10.1016\/j.jgo.2019.10.002","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"6837_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/cancers12010120","volume":"12","author":"R Palmieri","year":"2020","unstructured":"Palmieri R, Paterno G, De Bellis E, Mercante L, Buzzatti E, Esposito F, Del Principe MI, Maurillo L, Buccisano F, Venditti A (2020) Therapeutic choice in older patients with acute myeloid leukemia: A matter of fitness. Cancers (Basel) 12(1):120. https:\/\/doi.org\/10.3390\/cancers12010120","journal-title":"Cancers (Basel)"},{"issue":"20","key":"6837_CR16","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-06-721662","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405. https:\/\/doi.org\/10.1182\/blood-2016-06-721662","journal-title":"Blood"},{"issue":"3","key":"6837_CR17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2009-11-254441","volume":"116","author":"D Grimwade","year":"2010","unstructured":"Grimwade D, Hills RK, Moorman AV, National Cancer Research Institute Adult Leukaemia Working Group et al (2010) Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the united Kingdom medical research Council trials. Blood 116(3):354\u2013365. https:\/\/doi.org\/10.1182\/blood-2009-11-254441","journal-title":"Blood"},{"issue":"8","key":"6837_CR18","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","volume":"23","author":"CA Bellera","year":"2012","unstructured":"Bellera CA, Rainfray M, Mathoulin-P\u00e9lissier S, Mertens C, Delva F, Fonck M, Soubeyran PL (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol 23(8):2166\u20132172. https:\/\/doi.org\/10.1093\/annonc\/mdr587","journal-title":"Ann Oncol"},{"issue":"11","key":"6837_CR19","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1532-5415.2009.02497.x","volume":"57","author":"L Min","year":"2009","unstructured":"Min L, Yoon W, Mariano J, Wenger NS, Elliott MN, Kamberg C, Saliba D (2009) The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc 57(11):2070\u20132076. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02497.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"6837_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"6837_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/fampra\/11.3.260","volume":"11","author":"P D\u2019Ath","year":"1994","unstructured":"D\u2019Ath P, Katona P, Mullan E, Evans S, Katona C (1994) Screening, detection and management of depression in elderly primary care attenders. I: the acceptability and performance of the 15 item geriatric depression scale (GDS15) and the development of short versions. Fam Pract 11:260\u2013266. https:\/\/doi.org\/10.1093\/fampra\/11.3.260","journal-title":"Fam Pract"},{"issue":"3","key":"6837_CR22","first-page":"179-86","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. Autumn;9(3):179-86","journal-title":"Autumn"},{"issue":"2","key":"6837_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S (1991) The timed up & go: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39(2):142\u2013148. https:\/\/doi.org\/10.1111\/j.1532-5415.1991.tb01616.x","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"6837_CR24","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/s0749-0690(02)00059-9","volume":"18","author":"Y Guigoz","year":"2002","unstructured":"Guigoz Y, Lauque S, Vellas BJ (2002) Identifying the elderly at risk for malnutrition. The mini nutritional assessment. Clin Geriatr Med 18(4):737\u2013757. https:\/\/doi.org\/10.1016\/s0749-0690(02)00059-9","journal-title":"Clin Geriatr Med"},{"key":"6837_CR25","unstructured":"Bie\u0144 B, B\u0142\u0119dowski P, Broczek K et al (2013) Standardy post\u0119powania w Opiece geriatrycznej Stanowisko Polskiego Towarzystwa Gerontologicznego opracowane Przez ekspert\u00f3w Zespo\u0142u Ds. Gerontologii Przy Ministrze Zdrowia. Gerontologia Polska. 21(2):33\u201347"},{"key":"6837_CR26","first-page":"17","volume-title":"Koziarska-Ro\u015bciszewska M. Choroby Wieku podesz\u0142ego","author":"T Kostka","year":"2009","unstructured":"Kostka T (2009) Ca\u0142o\u015bciowa Ocena geriatryczna. In: Kostka T (ed) Koziarska-Ro\u015bciszewska M. Choroby Wieku podesz\u0142ego, 1rd edn. PZWL, Warszawa, pp 17\u201337","edition":"1"},{"key":"6837_CR27","first-page":"68","volume-title":"Geriatria z Elementami gerontologii og\u00f3lnej. Podr\u0119cznik Dla Lekarzy i student\u00f3w","author":"A Skalska","year":"2006","unstructured":"Skalska A (2006) Kompleksowa ocean geriatryczna. In: Grodzicki T, Kocemba J, Skalska A (eds) Geriatria z Elementami gerontologii og\u00f3lnej. Podr\u0119cznik Dla Lekarzy i student\u00f3w. ViaMedica, Gda\u0144sk, pp 68\u201375"},{"issue":"9","key":"6837_CR28","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/ptj\/80.9.896","volume":"80","author":"A Shumway-Cook","year":"2000","unstructured":"Shumway-Cook A, Brauer S, Woollacott M (2000) Predicting the probability for falls in community-dwelling older adults using the timed up & go test. Phys Ther 80(9):896\u2013903 PMID: 10960937","journal-title":"Phys Ther"},{"key":"6837_CR29","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","volume":"32","author":"H Wildiers","year":"2014","unstructured":"Wildiers H, Heeren P, Puts M et al (2014) International society of geriatric oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol 32:2595\u20132603. https:\/\/doi.org\/10.1200\/JCO.2013.54.8347","journal-title":"J Clin Oncol"},{"key":"6837_CR30","doi-asserted-by":"publisher","unstructured":"Klepin HD (2014) Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia. Hematol Am Soc Hematol Educ Program 8\u201313. https:\/\/doi.org\/10.1182\/asheducation-2014.1.8","DOI":"10.1182\/asheducation-2014.1.8"},{"issue":"2","key":"6837_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3324\/haematol.2012.067892","volume":"98","author":"B Deschler","year":"2013","unstructured":"Deschler B, Ihorst G, Platzbecker U, Germing U, M\u00e4rz E, de Figuerido M et al (2013) Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome. Haematologica 98(2):208\u2013216. https:\/\/doi.org\/10.3324\/haematol.2012.067892","journal-title":"Haematologica"},{"issue":"12","key":"6837_CR32","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/bloodadvances.2021006872","volume":"6","author":"EK Ritchie","year":"2022","unstructured":"Ritchie EK, Klepin HD, Storrick E, Major B, Le-Rademacher J, Wadleigh M, Walker A, Larson RA, Roboz GJ (2022) Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101. Blood Adv 6(12):3812\u20133820. https:\/\/doi.org\/10.1182\/bloodadvances.2021006872","journal-title":"Blood Adv"},{"issue":"11","key":"6837_CR33","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3109\/10428194.2016.1163345","volume":"57","author":"ME Hamaker","year":"2016","unstructured":"Hamaker ME, Augschoell J, Stauder R (2016) Clinical judgement and geriatric assessment for predicting prognosis and chemotherapy completion in older patients with a hematological malignancy. Leuk Lymphoma 57(11):2560\u20132567. https:\/\/doi.org\/10.3109\/10428194.2016.1163345","journal-title":"Leuk Lymphoma"},{"key":"6837_CR34","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1182\/blood.2022016867","volume":"140","author":"H D\u00f6hner","year":"2022","unstructured":"D\u00f6hner H, Wei A, Appelbaum F et al (2022) Diagnosis and management of acute myeloid leukemia in adults: 2022 recommendations from an international expert Panel, on behalf of the European leukemia net. Blood 140:1345\u20131377. https:\/\/doi.org\/10.1182\/blood.2022016867","journal-title":"Blood"},{"key":"6837_CR35","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","volume":"107","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, Anderson JE, Petersdorf SH (2006) Age and acute myeloid leukemia. Blood 107:3481\u20133485. https:\/\/doi.org\/10.1182\/blood-2005-09-3724","journal-title":"Blood"},{"issue":"18","key":"6837_CR36","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","volume":"113","author":"G Juliusson","year":"2009","unstructured":"Juliusson G, Antunovic P, Derolf \u00c5, Lehmann S, M\u00f6llg\u00e5rd L, Stockelberg D, Tidefelt U, Wahlin A, H\u00f6glund M (2009) Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish acute leukemia registry. Blood 113(18):4179\u20134187. https:\/\/doi.org\/10.1182\/blood-2008-07-172007","journal-title":"Blood"},{"issue":"22","key":"6837_CR37","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","volume":"116","author":"H Kantarjian","year":"2010","unstructured":"Kantarjian H, Ravandi F, O\u2019Brien S, Cortes J, Faderl S, Garcia-Manero G et al (2010) Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood 116(22):4422\u20134429. https:\/\/doi.org\/10.1182\/blood-2010-03-276485","journal-title":"Blood"},{"key":"6837_CR38","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/cncr.21723","volume":"106","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian H, O\u2019Brien S, Cortes J, Giles F, Faderl S, Jabbour E et al (2006) Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 106:1090\u20131098. https:\/\/doi.org\/10.1002\/cncr.21723","journal-title":"Cancer"},{"issue":"10","key":"6837_CR39","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1532-5415.2011.03614.x","volume":"59","author":"HD Klepin","year":"2011","unstructured":"Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Ellis LR et al (2011) The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc 59(10):1837\u20131846. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03614.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"6837_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s1040-8428(02)00062-8","volume":"43","author":"KS Garman","year":"2002","unstructured":"Garman KS, Cohen HJ (2002) Functional status and the elderly cancer patient. Crit Rev Oncol Hematol 43(3):191\u2013208. https:\/\/doi.org\/10.1016\/s1040-8428(02)00062-8","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"6837_CR41","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1365-2141.2006.06476.x","volume":"136","author":"FJ Giles","year":"2007","unstructured":"Giles FJ, Borthakur G, Ravandi F, Faderl S, Verstovsek S, Thomas D et al (2007) The Haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia. Br J Haematol 136(4):624\u2013627. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06476.x","journal-title":"Br J Haematol"},{"issue":"13","key":"6837_CR42","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1182\/blood-2007-06-096966","volume":"110","author":"ML Sorror","year":"2007","unstructured":"Sorror ML, Giralt S, Sandmaier BM et al (2007) Hematopoietic cell transplantation\u2013specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences. Blood 110(13):4606. https:\/\/doi.org\/10.1182\/blood-2007-06-096966","journal-title":"Blood"},{"issue":"1","key":"6837_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jgo.2019.02.002","volume":"11","author":"A Molga","year":"2019","unstructured":"Molga A, Wall M, Chhetri R, Wee LY, Singhal D, Edwards S et al (2019) Comprehensive geriatric assessment predicts Azacitidine treatment duration and survival in older patients with myelodysplastic syndromes. J Geriatr Oncol 11(1):114\u2013120. https:\/\/doi.org\/10.1016\/j.jgo.2019.02.002","journal-title":"J Geriatr Oncol"},{"issue":"8","key":"6837_CR44","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3324\/haematol.2014.103655","volume":"99","author":"LS Muffly","year":"2014","unstructured":"Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA et al (2014) Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica 99(8):1373\u20131379. https:\/\/doi.org\/10.3324\/haematol.2014.103655","journal-title":"Haematologica"},{"issue":"4","key":"6837_CR45","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/cancers15041002","volume":"15","author":"S Aydin","year":"2023","unstructured":"Aydin S, Passera R, Cerrano M, Giai V, D\u2019Ardia S, Iovino G, Dellacasa CM, Audisio E, Busca A (2023) Combining the HCT-CI, G8, and AML-Score for fitness evaluation of elderly patients with acute myeloid leukemia: A single center analysis. Cancers (Basel) 15(4):1002. https:\/\/doi.org\/10.3390\/cancers15041002","journal-title":"Cancers (Basel)"},{"issue":"Suppl 2","key":"6837_CR46","doi-asserted-by":"publisher","first-page":"S246","DOI":"10.1111\/j.1532-5415.2009.02503.x","volume":"57","author":"A Hurria","year":"2009","unstructured":"Hurria A (2009) Geriatric assessment in oncology practice. J Am Geriatr Soc 57(Suppl 2):S246\u2013S249. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02503.x","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"6837_CR47","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.critrevonc.2005.06.003","volume":"55","author":"M Extermann","year":"2005","unstructured":"Extermann M, Aapro M, Bernabeic R et al (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the international society of geriatric Oncology(SIOG). Crit Rev Oncol Hematol 55(3):241\u2013252. https:\/\/doi.org\/10.1016\/j.critrevonc.2005.06.003","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"6837_CR48","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3324\/haematol.2019.245803","volume":"105","author":"ERM Scheepers","year":"2020","unstructured":"Scheepers ERM, Vondeling AM, Thielen N, van der Griend R, Stauder R, Hamaker ME (2020) Geriatric assessment in older patients with a hematologic malignancy: a systematic review. Haematologica 105(6):1484\u20131493. https:\/\/doi.org\/10.3324\/haematol.2019.245803","journal-title":"Haematologica"},{"key":"6837_CR49","doi-asserted-by":"publisher","unstructured":"Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Pardee TS, Ellis LR, Powell BL (2013) Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia. Blood. 23;121(21):4287-94. https:\/\/doi.org\/10.1182\/blood-2012-12-471680","DOI":"10.1182\/blood-2012-12-471680"},{"issue":"5","key":"6837_CR50","doi-asserted-by":"publisher","first-page":"102254","DOI":"10.1016\/j.jgo.2025.102254","volume":"16","author":"AS Ciccone","year":"2025","unstructured":"Ciccone AS, Thibaudb V, Pugh K et al (2025) Geriatric assessment in older adults with acute myeloid leukemia: A young international society of geriatric oncology narrative review. J Geriatr Oncol 16(5):102254. https:\/\/doi.org\/10.1016\/j.jgo.2025.102254","journal-title":"J Geriatr Oncol"},{"issue":"22","key":"6837_CR51","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1200\/JCO.2018.78.8687","volume":"36","author":"SG Mohile","year":"2018","unstructured":"Mohile SG, Dale W, Somerfield MR et al (2018) Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 36(22):2326\u20132347. https:\/\/doi.org\/10.1200\/JCO.2018.78.8687","journal-title":"J Clin Oncol"},{"issue":"6","key":"6837_CR52","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ejon.2014.05.006","volume":"18","author":"A Velghe","year":"2014","unstructured":"Velghe A, De Petrovica S, Demuyncka R, Noensb L (2014) Validation of the G8 screening tool in older with aggressive haematological malignancies. Eur J Oncol Nurs 18(6):645\u2013648. https:\/\/doi.org\/10.1016\/j.ejon.2014.05.006","journal-title":"Eur J Oncol Nurs"},{"issue":"7","key":"6837_CR53","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.jgo.2023.101582","volume":"14","author":"K Fujita","year":"2023","unstructured":"Fujita K, Lee S, Morishita T, Negoro E, Oiwa K, Hara T, Tsurumi H, Ueda T, Yamauchi T (2023) Prognostic significance of the geriatric 8 score alone and included with genetic risk group in older adults with acute myeloid leukemia. J Geriatr Oncol 14(7):101582. https:\/\/doi.org\/10.1016\/j.jgo.2023.101582","journal-title":"J Geriatr Oncol"},{"key":"6837_CR54","doi-asserted-by":"publisher","unstructured":"Holmes HM, Des Bordes JK, Kebriaei P, Yennu S, Champlin RE, Giralt S, Mohile SG (2014) Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates. J Geriatr Oncol. 2014 5(4):422\u2009\u2013\u200930. https:\/\/doi.org\/10.1016\/j.jgo.2014.04.004","DOI":"10.1016\/j.jgo.2014.04.004"},{"issue":"4","key":"6837_CR55","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jgo.2015.02.005","volume":"6","author":"A Luciani","year":"2015","unstructured":"Luciani A, Biganzoli L, Colloca G et al (2015) Estimating the risk of chemotherapy toxicity in older patients with cancer: the role of the vulnerable elders Survey-13 (VES-13). J Geriatr Oncol 6(4):272\u2013279. https:\/\/doi.org\/10.1016\/j.jgo.2015.02.005","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"6837_CR56","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/ajh.27694","volume":"100","author":"VR Bhatt","year":"2025","unstructured":"Bhatt VR, Wichman CS, Koll TT et al (2025) A phase II trial of geriatric Assessment-Guided selection of treatment intensity in older adults with AML. Am J Hematol 100(7):1163\u20131172. https:\/\/doi.org\/10.1002\/ajh.27694","journal-title":"Am J Hematol"},{"issue":"8","key":"6837_CR57","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.leukres.2011.02.021","volume":"35","author":"MT Corsetti","year":"2011","unstructured":"Corsetti MT, Salvi F, Perticone S, Baraldi A, De Paoli L, Gatto S et al (2011) Hematologic improvement and response in elderly AML\/RAEB patients treated with valproic acid and low-dose Ara-C. Leuk Res 35(8):991\u2013997. https:\/\/doi.org\/10.1016\/j.leukres.2011.02.021","journal-title":"Leuk Res"},{"issue":"2","key":"6837_CR58","doi-asserted-by":"publisher","first-page":"e12810","DOI":"10.1111\/ecc.12810","volume":"27","author":"EG Umit","year":"2018","unstructured":"Umit EG, Baysal M, Demir AM (2018) Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age. Eur J Cancer Care (Engl) 27(2):e12810. https:\/\/doi.org\/10.1111\/ecc.12810","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"1","key":"6837_CR59","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1182\/blood.2021013671","volume":"138","author":"GJ Min","year":"2022","unstructured":"Min GJ, Cho BS, Park SS, Park S, Jeon YW, Shin SH et al (2022) Geriatric assessment predicts Non-Fatal toxicities and survival for intensively treated elderly acute myeloid leukemia: A prospective study. Blood 138(1):222. https:\/\/doi.org\/10.1182\/blood.2021013671","journal-title":"Blood"},{"key":"6837_CR60","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00432-006-0115-7","volume":"132","author":"U Wedding","year":"2006","unstructured":"Wedding U, R\u00f6hrig B, Klippstein A, Fricke HJ, Sayer HG, H\u00f6ffken K (2006) Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol 132:665\u2013671. https:\/\/doi.org\/10.1007\/s00432-006-0115-7","journal-title":"J Cancer Res Clin Oncol"},{"issue":"suppl 1","key":"6837_CR61","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1182\/blood-2018-99-112025","volume":"132","author":"LW Huang","year":"2018","unstructured":"Huang LW, Huang CY, Andreadis C et al (2018) Functional status is associated with outcomes after allogeneic stem cell transplantation for older patients with hematologic malignancies. Blood 132(suppl 1):3599. https:\/\/doi.org\/10.1182\/blood-2018-99-112025","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06837-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06837-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:03:25Z","timestamp":1771949005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06837-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6837"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06837-0","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}